SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/2DEEAD31B726C6C3CAC1E5553E2F826F97377004B5E35696C9B1760614258744668D941901D52F15CFEF4AD30BD515D9>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/2DEEAD31B726C6C3CAC1E5553E2F826F97377004B5E35696C9B1760614258744668D941901D52F15CFEF4AD30BD515D9
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/2DEEAD31B726C6C3CAC1E5553E2F826F97377004B5E35696C9B1760614258744668D941901D52F15CFEF4AD30BD515D9
http://www.w3.org/2000/01/rdf-schema#comment
"Allelic variation in HLA-DRB1 is associated with development of antidrug antibodies in cancer patients treated with atezolizumab that are neutralizing in vitro."
xsd:string
http://purl.uniprot.org/uniprot/#_7AB827B5918C0628C925B224B6A847C42FE5E52326D0CDDDBD24CFE21CF0A664ECD9BE4E757C7FAC663FC938DAEE2444
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/2DEEAD31B726C6C3CAC1E5553E2F826F97377004B5E35696C9B1760614258744668D941901D52F15CFEF4AD30BD515D9
http://purl.uniprot.org/uniprot/K0P0J2
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/2DEEAD31B726C6C3CAC1E5553E2F826F97377004B5E35696C9B1760614258744668D941901D52F15CFEF4AD30BD515D9
http://purl.uniprot.org/uniprot/#_K0P0J2-mappedCitation-35263013
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/2DEEAD31B726C6C3CAC1E5553E2F826F97377004B5E35696C9B1760614258744668D941901D52F15CFEF4AD30BD515D9